Biotechnology Instruments Market to Register 16.4% CAGR Amid Growing Preference for Minimally Invasive Surgical Treatments

Increasing Funds for Biotechnology and Pharmaceutical Research to Steer Biotechnology Instruments Market Past US$ 241.4 Bn by 2031

The biotechnology instruments market report published by Fact.MR provides in-depth market analysis and focused views on key trends projected to influence the sales in the market.  It also explicates the growth factors, latest developments, opportunities, and threats in the market across key geographies and segments, including component and end-use.

NEW YORK, April 7, 2022 /PRNewswire/ -- The biotechnology instruments market is projected to exceed US$ 53.3 Bn, at a CAGR of 16.4% during the forecast period (2022-2032). Sales of biotechnology instruments is projected to grow by 4.5x between 2022 and 2032, surpassing US$ 241.4 Bn in 2032.

Growing incidences of chronic illnesses and preference for minimally invasive surgeries is projected to boost the demand for personalized medication in the forthcoming years. This is likely to spur the sales of biotechnology instruments.

Similarly, application of in-vitro diagnostic (IVD) point-of-care devices in clinical labs and hospitals is surging. This is projected to create favorable growth prospects for the market.

Also, the advanced point-of-care (POC) testing systems will enable real-time transfer of patient data to electronic medical records for easy clinician reviewing. These advancements are projected to propel the demand for biotechnology instruments in the coming years.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=7171

Demand for surgical treatment, such as minimally invasive surgery (MIS), due to the increasing prevalence of diseases is estimated to rise. This is anticipated to fuel the demand in the market.

Further, integration of automation in biotechnology sector is projected to result in technical breakthroughs. This is expected to offer tremendous growth opportunities for the market players. Also, favorable government investment in the development of affordable and easy-to-use biotechnology equipment is estimated to supplement the development of the market.

Key Takeaways:

• Based on end-use, the hospitals and healthcare facilities segment is expected to dominate the market, registering a CAGR of 15.2% and 14.7%, respectively.
• North America biotechnology instruments market is expected to register fastest growth at 15.6% CAGR during 2022-2032.
• In terms of component, life science consumables is projected to account for 50% of the overall market share.
• Biotechnology instruments market registered year-over-year growth at 12.6% in 2022.

Growth Drivers:

• Increasing prevalence of cardiovascular disorders, diabetes, infectious diseases, cancer, and others will contribute to the growth in the market.
• Requirement of 2D and 3D cell cultures in the field of research and drug development is augmenting the sales of biotechnology instruments.

Restraints:

• Growing concerns regarding genetically modified crops, viruses, & bacteria and their impact on human health might hamper the growth in the market.
• Implementation of biotechnology instruments in the agricultural sector is likely to trigger the spread of diseases or native contaminate the original gene pool. This is anticipated to decline the sales in the near future.

Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7171

Competitive Landscape:

Key players present in the global biotechnology instruments market are focusing on advancing their production capabilities. These initiatives are likely spur the growth potential of the market in the coming years.

According to Fact.MR, the detailed analysis of companies will offer insights into the financial status, latest product launches, ongoing trends, and others. Some of the leading players are adopting growth strategies such as mergers and acquisitions to expand their global presence.

For instance,

• February 2021: Waters Corporation developed Waters ACQUITY PREMIER Solution, which is a next-generation liquid chromatography system. This device promotes the organization's innovation MaxPeak High-performance Surface technology.
• January 2021: Novasep's chromatography process equipment segment was brought by Sartorius Stedim Biotech. This deal help the latter gain control over the former organization's advanced chromatography systems and resin-based batch.

Key Companies Profiled by Fact.MR

• Agilent Technologies
• Alcon Inc.
• Bio-Rad Laboratories
• Candela Medical
• IIlumina Inc.
• Thermo Fisher Scientific Inc.
• AngioDynamics
• Abbott
• Danaher Corporation
• QIAGEN
• Novanta Inc.
• IRIDEX
• Becton, Dickinson, and Company
• BioMerieux SA
• BioTek Instruments, Inc.
• Cynosure, LLC
• Endress+Hauser (Analytik Jena GmbH)
• Zimmer MedizinSysteme
• F. Hoffmann-La Roche Ltd.
• Lumenis
• Merck KGaA
• Perkin Elmer, Inc.
• Siemens Healthineers
• Waters Corporation
• Tecan Group AG

More Valuable Insights on Biotechnology Instruments Market

In the latest study, Fact.MR provides focused views on growing opportunities and challenges of the global biotechnology instruments market. The report also offers unbiased analysis for the forecast period (2022-2032). This survey also reveals the key factors influencing the growth of the biotechnology instruments market through segmentation as follows:

By Component:

• Lab Automation Instruments
• Proteomics
• Genomics
• Sequencing
• Spatial Cell Analysis
• Other Lab Automation Instruments
• Medical Lasers
• Therapeutics
• Ophthalmic
• Ablation
• Life Science Consumables
• IVD Instruments

By End-use:

• Government & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Healthcare Facilities
• Other End-uses

By Region:

• North America
• Latin America
• Europe
• APAC
• MEA

Key Questions Covered in the Biotechnology Instruments Market Report

• What is the sales forecast of the global biotechnology instruments market?
• Who are the prominent global biotechnology instruments market?
• Which region is predicted to account for maximum share in the global biotechnology instruments market?
• What is expected revenue share of biotechnology instruments market in 2022?
• Which are the key factors shaping the growth in the global biotechnology instruments market?
• What is the expected value of global biotechnology instruments market during 2022-2032?

Explore Fact.MR's Coverage on the Healthcare Domain

DNA Polymerase Market: Demand for accuracy during the process of sequencing, cloning, or mutagenesis is projected to increase the demand for effective PCR enzymes. This is anticipated to create prolific opportunities for the market. Besides this, the increasing investments in the research & development (R&D) activities will augment the demand in the coming years.

Polymerase Chain Reaction Market: Emergence of diseases such as COVID-19 is projected to create immense opportunities for the market. Also, the accuracy of PCR techniques in the diagnosis of disease-causing microbes is likely to fuel the development of the market.

Biotechnology and Pharmaceutical Services Outsourcing Market: Rise in the number of contrarieties in intellectual property rights and fraudulent cases is likely to compel the biotechnology and pharmaceutical companies to adopt consulting services. Such causes are predicted to boost the growth in the market.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, chemical, and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making.

Contact: 
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: [email protected]

SOURCE Fact.MR